MEDI0639
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MEDI0639, covering 2017-05-02 to 2017-05-02. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI0639 in Advanced Solid Tumors [Phase 1]